News

Purdue Pharma’s $7B opioid settlement could advance after states back it
OxyContin maker Purdue Pharma ’s latest plan to settle thousands of lawsuits over the toll of opioids could soon move forward ...
$7.4 billion Purdue Pharma opioid settlement backed by dozens of more states
More states, territories and Washington, D.C., have signed on to a settlement with drugmaker Purdue Pharma and the Sackler ...
Purdue Pharma Reaches $7.4 Billion Settlement Over Opioid Marketing
The deal ends the Sackler family's ownership of the company and bans them from ever selling opioids in the U.S. again.
Purdue Pharma $7.4 billion opioid settlement wins broad support from state officials
The multi-billion-dollar payment is meant to resolve claims that the drugmaker's pain medication, OxyContin, caused an opioid ...
In U.S. opioid crisis, states say yes to $7B Purdue Pharma settlement
All 50 states, D.C., and four U.S. territories signed off on the multi-billion dollar settlement proposal with OxyContin ...
Georgia could receive up to $126M in Purdue Pharma opioid settlement
Georgia could receive up to $126 million from a national opioid settlement with Purdue Pharma and the Sackler family.
Ohio, other states agree to $7.4B opioid settlement with Purdue Pharma
Purdue Pharma has won support from the attorneys general of 55 states including Ohio for its $7.4 billion settlement to ...
States agree to $7.4 billion settlement with Purdue Pharma in opioid case
Fifty-five state attorneys general have agreed to a $7.4 billion settlement with Purdue Pharma and the Sackler family over ...
Purdue Pharma $7.4 Billion Opioid Settlement Wins Broad Support From US States
(Reuters) -The attorneys general of all 50 U.S. states, Washington, D.C. and four U.S. territories have agreed to a $7.4 ...
Purdue Pharma receives broad state support for $7.4 billion opioid settlement
WASHINGTON — Purdue Pharma has gained support from attorneys general in 55 U.S. states and territories for a $7.4 billion ...
States agree to $7.4 billion settlement with Purdue Pharma in opioid litigation
All eligible U.S. states and territories have agreed to sign a $7.4 billion settlement with the company and family behind OxyContin, officials announced Monday.